POMONA, N.Y. – Teva Pharmaceuticals, said to be one of the nation’s largest drug producers, is closing its Pomona plant and laying off dozens of employees, the company said this week.
According to Teva communications director Michele Pelkowski, the plant at 223 Quaker Road has been winding down for a while.
About 44 employees were let go between 2014 and 2015, according to bizjournals.com. The current round of job cutbacks involves 80 employees at the site, Pelkowski said.
Teva, an Israeli company, has its American headquarters in North Wales, Pa. According to Teva, it employs close to 60,000 people around the world and had revenues in 2015 of about $19.7 billion.
With its acquisition of Actavis Generics, a pharma headquartered in Parsippany-Troy Hills, N.J., Teva plans to move certain research and development activities from Pomona to Elizabeth, N.J., Pelkowski said. Teva is forecasting 130 positions will be available in Elizabeth, she added.
She said the company also is working with employees to help them find jobs elsewhere. They also are being offered severance pay, Pelkowski said.
The plant will be closed by the end of February, according to a report by lohud.com.
Teva’s Pomona facility was fined $8,500 by the Occupational Safety and Health Administration in 2014 for violating workplace safety laws, according to another report by lohud.com. Around the same time, the company wound up in U.S. Supreme Court in a battle regarding a drug patent, bizjournals.com reported. The essence of the case was the right of companies to make generic drugs after the original patents had expired, according to the bizjournals.com story.
Click here to sign up for Daily Voice's free daily emails and news alerts.